Table 3.
Parameters | Effective IPL (n = 32) | Ineffective IPL (n = 16) | P value |
Gender | 1.000∗ | ||
Male | 9 (28.1) | 5 (31.3) | |
Female | 23 (71.9) | 11 (68.7) | |
Age (yr) | .032 ∗ | ||
18-39 | 20 (62.5) | 4 (25.0) | |
40 and above | 12 (37.5) | 12 (75.0) | |
Duration of MGD (mo) | .504∗ | ||
<3 | 16 (50.0) | 8 (50.0) | |
3-<6 | 8 (25.0) | 6 (37.5) | |
≥6 | 8 (25.0) | 2 (12.5) | |
Time of VDT usage (h/d) | .665∗ | ||
0-<4 | 10 (31.3) | 6 (37.5) | |
≥4 | 22 (68.7) | 10 (62.5) | |
Severity of MGD | .004 ∗ | ||
Mild | 4 (12.5) | 2 (12.5) | |
Moderate | 21 (65.6) | 3 (18.7) | |
Severe | 7 (21.9) | 11 (68.8) | |
Baseline TBUT (s) | 1.50 (1.00, 2.00) | 2.00 (1.00, 2.00) | .592† |
Baseline S ɪ t (mm/5 min) | 9.50 (4.00, 13.00) | 4.00 (2.00, 7.75) | .024 † |
Baseline CFS (score) | 2.00 (1.00, 4.00) | 2.00 (1.00, 3.00) | .548† |
Baseline OSDI (score) | 43.37 ± 21.39 | 37.91 ± 13.00 | .014 ‡ |
Baseline EMAS (score) | 2.00 (2.00, 2.00) | 2.00 (1.25, 2.00) | .639† |